Omrix Biopharmaceuticals News
Most Popular Omrix Biopharmaceuticals Story
ALSO NOTED: FDA OKs human thrombin; A new cancer research company; Compugen inks drug pact; and much more...
> Shares of Omrix surged this morning on the news that the FDA had approved Evithrom, a protein used to control bleeding during surgery. This is the first human thrombin to gain approval since Read more...
Latest Headlines
- November 24, 2008
- October 9, 2008
- August 19, 2008
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
